May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
"Double - Eyelid Glue" in the Management of Severe Blepharoptosis
Author Affiliations & Notes
  • T. H. Osaki
    Ophthalmology, Santa Casa of Sao Paulo, Sao Paulo, Brazil
  • M. H. Osaki
    Ophthalmology, Vision Institute/ Federal University of Sao Paulo, Sao Paulo, Brazil
  • R. Belfort, Jr.
    Ophthalmology, Vision Institute/ Federal University of Sao Paulo, Sao Paulo, Brazil
  • T. Osaki
    Ophthalmology, Vision Institute/ Federal University of Sao Paulo, Sao Paulo, Brazil
  • Footnotes
    Commercial Relationships  T.H. Osaki, None; M.H. Osaki, None; R. Belfort, None; T. Osaki, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 3351. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. H. Osaki, M. H. Osaki, R. Belfort, Jr., T. Osaki; "Double - Eyelid Glue" in the Management of Severe Blepharoptosis. Invest. Ophthalmol. Vis. Sci. 2008;49(13):3351.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To describe the results of a conservative technique for the treatment of progressive myopathic blepharoptosis using a "double-eyelid glue", which is a cosmetic made of natural rubber latex and has been used to give the appearance of an eyelid crease in Asian women with single eyelid.

Methods: : 11 consecutive patients with mitochondrial myopathy were studied. Marginal reflex distance (MRD-1), pictures and visual fields were obtained previously and after the treatment.

Results: : All patients described a better appearance after the application of the "double-eyelid glue" and none had allergic response to it. All cases had an increase in MRD-1 and improvement of the visual fields.

Keywords: eyelid • visual fields • keratitis 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×